These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30026685)

  • 1. Recent Advances in the Therapeutic and Diagnostic Use of Liposomes and Carbon Nanomaterials in Ischemic Stroke.
    Fernandes LF; Bruch GE; Massensini AR; Frézard F
    Front Neurosci; 2018; 12():453. PubMed ID: 30026685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes for drug delivery in stroke.
    Bruch GE; Fernandes LF; Bassi BLT; Alves MTR; Pereira IO; Frézard F; Massensini AR
    Brain Res Bull; 2019 Oct; 152():246-256. PubMed ID: 31323280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke.
    Fukuta T; Oku N; Kogure K
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders.
    Waris A; Ali A; Khan AU; Asim M; Zamel D; Fatima K; Raziq A; Khan MA; Akbar N; Baset A; Abourehab MAS
    Nanomaterials (Basel); 2022 Jun; 12(13):. PubMed ID: 35807977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
    Fukuta T; Ishii T; Asai T; Oku N
    Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Chemically Engineered Nanostructures Impact on Ischemic Stroke Treatment.
    Sri Kanaka Durga Vijayalakshmi G; Puvvada N
    ACS Omega; 2023 Dec; 8(48):45188-45207. PubMed ID: 38075770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the development of nanomedicines for the treatment of ischemic stroke.
    Tian X; Fan T; Zhao W; Abbas G; Han B; Zhang K; Li N; Liu N; Liang W; Huang H; Chen W; Wang B; Xie Z
    Bioact Mater; 2021 Sep; 6(9):2854-2869. PubMed ID: 33718667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
    Fukuta T
    Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to the ischemic brain.
    Thompson BJ; Ronaldson PT
    Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke.
    Lin X; Li N; Tang H
    Front Cell Neurosci; 2022; 16():885190. PubMed ID: 35836741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic Opportunities.
    Al-Ahmady ZS; Jasim D; Ahmad SS; Wong R; Haley M; Coutts G; Schiessl I; Allan SM; Kostarelos K
    ACS Nano; 2019 Nov; 13(11):12470-12486. PubMed ID: 31693858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced drug delivery system against ischemic stroke.
    Zhang S; Zhou Y; Li R; Chen Z; Fan X
    J Control Release; 2022 Apr; 344():173-201. PubMed ID: 35248645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
    Fukuta T; Kogure K
    Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke.
    Nair SB; Dileep A; Rajanikant GK
    Curr Med Chem; 2012; 19(5):744-56. PubMed ID: 22204347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nanomaterials for clinical neuroscience.
    Gilmore JL; Yi X; Quan L; Kabanov AV
    J Neuroimmune Pharmacol; 2008 Jun; 3(2):83-94. PubMed ID: 18210200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain.
    Zamani P; Penson PE; Barreto GE; Sahebkar A
    Curr Med Chem; 2021; 28(21):4152-4171. PubMed ID: 33342401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing nanobiotechnology for cerebral ischemic stroke management.
    Tang L; Fu C; Zhang A; Li X; Cao Y; Feng J; Liu H; Dong H; Wang W
    Biomater Sci; 2023 Jan; 11(3):791-812. PubMed ID: 36545758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke.
    Wang K; Zhou W; Jin X; Shang X; Wu X; Wen L; Li S; Hong Y; Ke J; Xu Y; Yuan H; Hu F
    Nanoscale; 2023 Jul; 15(27):11625-11646. PubMed ID: 37377137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.